Health and Pharmaceuticals

Medibank proceeds won't be siphoned: Cormann

by AAP
Government won't be siphoning off proceeds from Medibank Private sale to pay down debt.

Prognosis is for a healthy profit from the Medibank float

The success of the Medibank float has whetted the government's appetite for the privatisation of more state assets.

Primary Health Care MD flags retirement

Founder and MD of medical services provider Edmund Bateman will retire in January 2015.

Medibank IPO raises $5.679bn

Institutions pay $2.15 a share as govt allocates 60% of shares to retail investors.

Medibank: a few winners, many losers

At first glance the privatisation of Medibank might look like a good deal but on closer inspection it's actually a bit of a shocker for taxpayers.

Female directors outnumber men on Medibank board

Health provider will be only top 100 company with a majority of women on its board.

GOP sues over Obama's health law

Lawsuit focuses on policy changes made after Affordable Care Act was signed into law.

Estia locks in $625m ahead of IPO

Estia Health has secured $625m from cornerstone investors for its planned IPO, which values the aged care provider at over $1bn.

Medibank set for strong first day

by AAP
Hundreds of thousands of investors are all but guaranteed to make a tidy first-day gain when Medibank floats on Tuesday.

All smiles on dental debut

Shares in dental care chain Pacific Smiles jumped by more than a third on its ASX debut today.

Sonic slumps on guidance cut

Pathology provider downwardly revises EBITDA growth to 2-4%, shares fall 6%.

Healthe Care’s trip sounds out buyers

Trip to Asia by Healthe Care’s management linked to potential trade sale.

Aged care group targets $NZ80m float

The New Zealand retirement village group Arvida joins the trend to go public.

Actavis to buy Botox-maker Allergan

by AFP
Actavis takeover will create one of the top 10 global pharmaceutical companies by sales.

Quadrant locks in key Estia bids

Private equity firm secures several cornerstone investors for aged-care float.

Big brokers already trading Medibank Private

Medibank Private’s institutional book build is expected to price at around $2.10, far above the indicative price range set by the government.

Medibank retail offer exceeds $4.8bn

1 comment
Government says retail uptake is still being processed but total general public demand will exceed $4.8 billion.

Estia IPO to raise up to $834m

Aged care provider Estia Health has set an indicative IPO range of $5.17 to $6.96 a share, according to its prospectus.

Four in chase for Sydney hospital

Four bidders have been shortlisted for the $1bn Royal North Shore Hospital.

Interest building in global health corp

by AAP
World bank outlines progress on plans for 'virtual economic buffer', reiterates risk of future pandemics.